Clinical and immunologic effects of component peptides in allervax® Cat

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 224-226

  Norman, Philip S ^a   Nicodemus, Christopher F ^b   Creticos, Peter S ^a   Wood, Robert A ^a   Eggleston, Peyton A ^a   Lichtenstein, Lawrence M ^a   Kagey Sobotka, Anne ^a   Proud, David ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b ImmuLogic Pharmaceutical Corporation   (United States)

Author keywords

Cat allergy; Immunotherapy; Peptides

Indexed keywords

ALLERGEN; ALLERVAX; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; PEPTIDE; PLACEBO; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CAT; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; PATIENT; PRICK TEST; PRIORITY JOURNAL; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ALLERGENS; ANIMALS; CATS; GLYCOPROTEINS; HUMANS; HYPERSENSITIVITY; PEPTIDE FRAGMENTS;

EID: 0030939933     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237553     Document Type: Article

References (8)

1. Lichtenstein LM: Allergy and the immune system, Sci Am 1993;269:117-124.
2. Ricci M, Rossi O, Bcrtoni M, Matucci A: The importance of Th2-like cells in the pathogenesis of airway allergic inflammation, Clin Exp Allergy 1993;23:360-369.
3. Nceljes JJ, Mombouafg F: Cell biology of antigen presentation, Curr Opin Immunol 1993:5: 27-34.
4. Higgins JA, Lamb JR, Marsh SGE, Tonks S, Hayball JD, Rosen-Bronson S, Bodmer JG, O'Hehir RE: Peptide-induced nonresponsivc-ness of HLA-DP restricted human T cells reactive with Dermatophagoides spp, (house dust mite), J Allergy Clin Immunol 1992:90: 749-756.
5. Briner TJ, Kuo MC, Keating KM, Rogers BL: Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I, Proc Natl Acad Sci USA 1993;90:7608-7612.
6. Counsell CM, Bond JF, Ohman JL Jr., Green-stcin JL, Garman RF: Definition of the human T cell epitopes of Fel d I, the major allergen of the domestic cat, J Allergy Clin Immunol 1996; 98:884-894.
7. Norman PS, Ohman JL, Jr., Long AA, Crcticos PS, Gefter MS, Shaked Z, Wood RA, Hafner KB, Rao P, Lichtenstein LM, Jones Nil, Nico-demus CF: Treatment of Cat Allergy with T cell Reactive Peptides, Am J Rcspir Crit Care Med 1996;154:1623-1628.
8. Norman PS, Ohman JL, Long AA, Crcticos PS, Shaked Z, Wood RA, Eggleston PA, Jones NIL Nicodemus CF: Follow on study of the first clinical trial with T cell defined peptides from cat allergen Fel d 1 (abstract), J Allergy Clin Immunol 1995:95:259